Search Page
The search found 15 results in 0.069 seconds.
Search results
-
Ion channels
Ion channels are pore-forming protein complexes that facilitate the flow of ions across the hydrophobic core of cell membranes.
media - 23/05/2014 - 10:20am
-
Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects.
This 22-page open-access article published by Zahra Pourpak et al. in the Journal Recent Patents on Inflammation & Allergy Drug Discovery, describes in detail the WHO definition of adverse drug reactions (ADRs), the common features, classification according to Rawlins and Thompson and beyond. The authors also provide a comprehensive description of predictable Type A, which is dose-related pharmacological effects and the unpredictable, bizarre, Type B hypersensitivity reactions. Tables 1 and 2 detail the common examples of clinical and genetic risks of Type B ADRs.
efaccena - 12/12/2017 - 10:28am
-
Antidepressant drugs
In patients with moderate to severe depression routine antidepressant therapy is effective (as highlighted by Cipriani et al. (2018) following meta-analysis of results from clinical trials of 21 different antidepressants)- and is recommended to be combined with psychological therapy. Drug treatment of mild depression may also be considered in patients with a history of moderate or severe depression.
smaxwell - 10/10/2014 - 7:55pm
-
Drugs for HIV infections
HIV medications are generally classified according to their mechanistic action.
The main classes are:
- Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
- Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
- Protease Inhibitors (PIs)
- Entry (or Fusion) Inhibitors
- Integrase Inhibitors (or integrase strand transfer inhibitors (INSTIs))
- Attachment Inhibitors
- Capsid Inhibitors
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
efaccena - 29/08/2016 - 11:15am
-
Lipid-lowering drugs
There are several classes of established lipid-lowering, or antihyperlipidemic drugs available to the prescriber.
The choice of which agent to use depends greatly on the patient's cholesterol profile, cardiovascular, liver and kidney function.
smaxwell - 10/10/2014 - 9:16am